
Carey Kernodle Anders
Professor of MedicinePositions
Professor of Medicine in the School of Medicine
2020 School of Medicine
Chief, Division of Medical Oncology in the School of Medicine
2021 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2019 School of Medicine
Education
M.D. 2002
2002 East Carolina University, Brody School of Medicine
Internal Medicine Residency, MEDICINE
2005 Duke University, School of Medicine
Hematololgy-Oncology Fellowship, MEDICINE
2008 Duke University, School of Medicine
Clinical Trials
Publications, Grants & Awards
- Grants (28)
- Academics Articles (3)
Showing 1-5 of 28
DATO-BASE: A phase 2 trial of DATOpotamab-deruxtecan for breast cancer Brain metAstaSEs
Dana-Farber Cancer Institute
A single shot therapy will accelerate the elimination of breast cancer
United States Army Medical Research Acquisition Activity
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
National Institutes of Health
Incyclix INX-315-01
Incyclix Bio, LLC
DCI Centers, Cancer Types & Labs
Offices & Contact
Dept of Medicine
Durham, NC
27710 Box 3381, Seeley Mudd Building
Durham, NC
27710
Durham, NC
27710 Box 3381, Seeley Mudd Building
Durham, NC
27710